123 related articles for article (PubMed ID: 37393022)
1. The Feasibility of Quality Assurance in the TOPGEAR International Phase 3 Clinical Trial of Neoadjuvant Chemoradiation Therapy for Gastric Cancer (an Intergroup Trial of the AGITG/TROG/NHMRC CTC/EORTC/CCTG).
Lukovic J; Moore AJ; Lee MT; Willis D; Ahmed S; Akra M; Hortobagyi E; Kron T; Lim Joon D; Liu A; Ryan J; Thomas M; Wall K; Ward I; Wiltshire KL; O'Callaghan CJ; Wong RKS; Ringash JG; Haustermans K; Leong T
Int J Radiat Oncol Biol Phys; 2023 Dec; 117(5):1096-1106. PubMed ID: 37393022
[TBL] [Abstract][Full Text] [Related]
2. TOPGEAR: a randomised phase III trial of perioperative ECF chemotherapy versus preoperative chemoradiation plus perioperative ECF chemotherapy for resectable gastric cancer (an international, intergroup trial of the AGITG/TROG/EORTC/NCIC CTG).
Leong T; Smithers BM; Michael M; Gebski V; Boussioutas A; Miller D; Simes J; Zalcberg J; Haustermans K; Lordick F; Schuhmacher C; Swallow C; Darling G; Wong R
BMC Cancer; 2015 Jul; 15():532. PubMed ID: 26194186
[TBL] [Abstract][Full Text] [Related]
3. TOPGEAR: A Randomized, Phase III Trial of Perioperative ECF Chemotherapy with or Without Preoperative Chemoradiation for Resectable Gastric Cancer: Interim Results from an International, Intergroup Trial of the AGITG, TROG, EORTC and CCTG.
Leong T; Smithers BM; Haustermans K; Michael M; Gebski V; Miller D; Zalcberg J; Boussioutas A; Findlay M; O'Connell RL; Verghis J; Willis D; Kron T; Crain M; Murray WK; Lordick F; Swallow C; Darling G; Simes J; Wong R
Ann Surg Oncol; 2017 Aug; 24(8):2252-2258. PubMed ID: 28337660
[TBL] [Abstract][Full Text] [Related]
4. Radiation Therapy Quality Assurance (RTQA) of Concurrent Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung Cancer in the PROCLAIM Phase 3 Trial.
Brade AM; Wenz F; Koppe F; Lievens Y; San Antonio B; Iscoe NA; Hossain A; Chouaki N; Senan S
Int J Radiat Oncol Biol Phys; 2018 Jul; 101(4):927-934. PubMed ID: 29976505
[TBL] [Abstract][Full Text] [Related]
5. Optimizing Radiation Therapy Quality Assurance in Clinical Trials: A TROG 08.03 RAVES Substudy.
Trada Y; Kneebone A; Paneghel A; Pearse M; Sidhom M; Tang C; Wiltshire K; Haworth A; Fraser-Browne C; Martin J
Int J Radiat Oncol Biol Phys; 2015 Dec; 93(5):1045-51. PubMed ID: 26475066
[TBL] [Abstract][Full Text] [Related]
6. The Impact of Clinical Trial Quality Assurance on Outcome in Head and Neck Radiotherapy Treatment.
Zhong H; Men K; Wang J; van Soest J; Rosenthal D; Dekker A; Zhang Z; Xiao Y
Front Oncol; 2019; 9():792. PubMed ID: 31497534
[No Abstract] [Full Text] [Related]
7. Global harmonization of quality assurance naming conventions in radiation therapy clinical trials.
Melidis C; Bosch WR; Izewska J; Fidarova E; Zubizarreta E; Ulin K; Ishikura S; Followill D; Galvin J; Haworth A; Besuijen D; Clark CH; Miles E; Aird E; Weber DC; Hurkmans CW; Verellen D
Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1242-9. PubMed ID: 25539374
[TBL] [Abstract][Full Text] [Related]
8. Impact of deviations in target volume delineation - Time for a new RTQA approach?
Cox S; Cleves A; Clementel E; Miles E; Staffurth J; Gwynne S
Radiother Oncol; 2019 Aug; 137():1-8. PubMed ID: 31039468
[TBL] [Abstract][Full Text] [Related]
9. Quality Assurance of Dose-Escalated Radiation Therapy in a Randomized Trial for Locally Advanced Oesophageal cancer.
Boustani J; Rivin Del Campo E; Blanc J; Peiffert D; Benezery K; Pereira R; Rio E; Le Prisé E; Créhange G; Huguet F
Int J Radiat Oncol Biol Phys; 2019 Oct; 105(2):329-337. PubMed ID: 31299242
[TBL] [Abstract][Full Text] [Related]
10. Lungtech, a phase II EORTC trial of SBRT for centrally located lung tumours - a clinical physics perspective.
Lambrecht M; Melidis C; Sonke JJ; Adebahr S; Boellaard R; Verheij M; Guckenberger M; Nestle U; Hurkmans C
Radiat Oncol; 2016 Jan; 11():7. PubMed ID: 26791788
[TBL] [Abstract][Full Text] [Related]
11. Impact of radiotherapy protocol adherence in NSCLC patients treated with concurrent chemoradiation: RTQA results of the PET-Plan trial.
Gkika E; Schimek-Jasch T; Kremp S; Lenz S; Stockinger M; Schaefer-Schuler A; Mix M; Küsters A; Tosch M; Hehr T; Eschmann SM; Bultel YP; Hass P; Fleckenstein J; Thieme AH; Dieckmann K; Miederer M; Holl G; Rischke HC; Adebahr S; König J; Binder H; Grosu AL; Nestle U
Radiother Oncol; 2021 Oct; 163():32-38. PubMed ID: 34311004
[TBL] [Abstract][Full Text] [Related]
12. Organ at risk delineation for radiation therapy clinical trials: Global Harmonization Group consensus guidelines.
Mir R; Kelly SM; Xiao Y; Moore A; Clark CH; Clementel E; Corning C; Ebert M; Hoskin P; Hurkmans CW; Ishikura S; Kristensen I; Kry SF; Lehmann J; Michalski JM; Monti AF; Nakamura M; Thompson K; Yang H; Zubizarreta E; Andratschke N; Miles E
Radiother Oncol; 2020 Sep; 150():30-39. PubMed ID: 32504762
[TBL] [Abstract][Full Text] [Related]
13. Quality assurance of radiotherapy in the ongoing EORTC 1420 "Best of" trial for early stage oropharyngeal, supraglottic and hypopharyngeal carcinoma: results of the benchmark case procedure.
Stelmes JJ; Vu E; Grégoire V; Simon C; Clementel E; Kazmierska J; Grant W; Ozsahin M; Tomsej M; Vieillevigne L; Fortpied C; Hurkmans EC; Branquinho A; Andratschke N; Zimmermann F; Weber DC
Radiat Oncol; 2021 May; 16(1):81. PubMed ID: 33933118
[TBL] [Abstract][Full Text] [Related]
14. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
15. The radiotherapy quality assurance gap among phase III cancer clinical trials.
Corrigan KL; Kry S; Howell RM; Kouzy R; Jaoude JA; Patel RR; Jhingran A; Taniguchi C; Koong AC; McAleer MF; Nitsch P; Rödel C; Fokas E; Minsky BD; Das P; Fuller CD; Ludmir EB
Radiother Oncol; 2022 Jan; 166():51-57. PubMed ID: 34838891
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy Versus Chemotherapy Plus Chemoradiation as Neoadjuvant Therapy for Resectable Gastric Adenocarcinoma: A Multi-institutional Analysis.
Allen CJ; Pointer DT; Blumenthaler AN; Mehta RJ; Hoffe SE; Minsky BD; Smith GL; Blum M; Mansfield PF; Ikoma N; Das P; Ajani J; Dineen SP; Fleming JB; Badgwell BD; Pimiento JM
Ann Surg; 2021 Oct; 274(4):544-548. PubMed ID: 34132693
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial.
Cats A; Jansen EPM; van Grieken NCT; Sikorska K; Lind P; Nordsmark M; Meershoek-Klein Kranenbarg E; Boot H; Trip AK; Swellengrebel HAM; van Laarhoven HWM; Putter H; van Sandick JW; van Berge Henegouwen MI; Hartgrink HH; van Tinteren H; van de Velde CJH; Verheij M;
Lancet Oncol; 2018 May; 19(5):616-628. PubMed ID: 29650363
[TBL] [Abstract][Full Text] [Related]
18. Study protocol of a randomized phase III trial of comparing preoperative chemoradiation with preoperative chemotherapy in patients with locally advanced gastric cancer or esophagogastric junction adenocarcinoma: PREACT.
Liu X; Jin J; Cai H; Huang H; Zhao G; Zhou Y; Wu J; Du C; Long Z; Fang Y; Ma M; Li G; Zhou M; Yin J; Zhu X; Zhu J; Sheng W; Huang D; Zhu H; Zhang Z; Lu Q; Xie L; Zhang Z; Wang Y
BMC Cancer; 2019 Jun; 19(1):606. PubMed ID: 31221115
[TBL] [Abstract][Full Text] [Related]
19. [Neoadjuvant chemoradiotherapy combined with surgery versus direct surgery in the treatment of Siewert type II and III adenocarcinomas of the esophagogastric junction: long-term prognostic analysis of a prospective randomized controlled trial].
Tian Y; Wang Q; Wang J; Qiao XY; Zhang J; Lin YC; Li Y; Fan LQ; Yang PG; Zhao Q
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):128-137. PubMed ID: 33508918
[No Abstract] [Full Text] [Related]
20. Use of EORTC target definition guidelines for dose-intensified salvage radiation therapy for recurrent prostate cancer: results of the quality assurance program of the randomized trial SAKK 09/10.
Sassowsky M; Gut P; Hölscher T; Hildebrandt G; Müller AC; Najafi Y; Kohler G; Kranzbühler H; Guckenberger M; Zwahlen DR; Azinwi NC; Plasswilm L; Takacs I; Reuter C; Sumila M; Manser P; Ost P; Böhmer D; Pilop C; Aebersold DM; Ghadjar P
Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):534-41. PubMed ID: 23972722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
